
CNS Pharmaceuticals, Inc.
NASDAQ:CNSP
Overview | Financials
Company Name | CNS Pharmaceuticals, Inc. |
Symbol | CNSP |
Currency | USD |
Price | 1.14 |
Market Cap | 3,356,593 |
Dividend Yield | 0% |
52-week-range | 0.772 - 800 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John Michael Climaco Esq., J.D. |
Website | https://www.cnspharma.com |
An error occurred while fetching data.
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD